MediWound (MDWD) Stock Highlights

16.31 | +1.68%

2024-06-03 03:48:12

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from the United States.

Statistics

Range Today

15.84 16.89

Volume Today 38.7K

Range 1 Year

7.1 19.86

Volume 1 Year 9.38M

Range 3 Year

7.1 43.54

Volume 3 Year 23.94M

Range 10 Year

7.1 89.25

Volume 10 Year 40.44M

Highlights

Market Capitalization 151.42M (small)

Floating Shares 5.84M

Current Price 16.31

Price To Earnings -11.96

Price To Revenue 6.94

Price To Book 4.76

Earnings Per Share -1.36

Payout Ratio 0%

Performance

Latest +1.68%

1 Month -13.34%

3 Months +15.59%

6 Months +82.03%

1 Year +83.67%

3 Years -32.27%

5 Years -43.15%

10 Years -80.24%

Benchmarks

Market Capitalization

246 / 368

Gross Profits

94 / 278

Total Revenue

149 / 300

Total Rank

193 / 368

Free Cashflow

79 / 352

Performance 5 years

178 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.